share_log

4: Statement of changes in beneficial ownership of securities-Director McNealey Jennifer Isacoff

SEC ·  May 16 04:55
Summary by Futu AI
Jennifer Isacoff McNealey, associated with Conduit Pharmaceuticals, has engaged in a transaction involving the company's stock on May 13, 2024. The specific details of the transaction, including the number of shares, the nature of the shares, the transaction price, and the total value of the shares, have not been disclosed. The action type and status, as well as the number of shares held by McNealey after the transaction, are also not provided in the announcement.
Jennifer Isacoff McNealey, associated with Conduit Pharmaceuticals, has engaged in a transaction involving the company's stock on May 13, 2024. The specific details of the transaction, including the number of shares, the nature of the shares, the transaction price, and the total value of the shares, have not been disclosed. The action type and status, as well as the number of shares held by McNealey after the transaction, are also not provided in the announcement.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.